Related references
Note: Only part of the references are listed.Tamoxifen as a new therapeutic tool for neutrophilic lung inflammation
Barbara Perez et al.
RESPIROLOGY (2016)
Tamoxifen Suppresses the Growth of Malignant Pleural Mesothelioma Cells
Cormac J. Jennings et al.
ANTICANCER RESEARCH (2016)
Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemia
Samy A. F. Morad et al.
JOURNAL OF LIPID RESEARCH (2016)
Tamoxifen Induces Apoptosis of Leishmania major Promastigotes in Vitro
Masoud Doroodgar et al.
KOREAN JOURNAL OF PARASITOLOGY (2016)
Prognostic role of sex steroid receptors in pancreatic adenocarcinoma
Despoina Georgiadou et al.
PATHOLOGY RESEARCH AND PRACTICE (2016)
Tamoxifen in combination with temozolomide induce a synergistic inhibition of PKC-pan in GBM cell lines
Joana Balca-Silva et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2015)
Tamoxifen regulation of sphingolipid metabolism-Therapeutic implications
Samy A. F. Morad et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2015)
Inhibition of angiogenesis by selective estrogen receptor modulators through blockade of cholesterol trafficking rather than estrogen receptor antagonism
Joong Sup Shim et al.
CANCER LETTERS (2015)
Anti-Mycobacterial Activity of Tamoxifen Against Drug-Resistant and Intra-Macrophage Mycobacterium tuberculosis
Woong Sik Jang et al.
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2015)
A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas
Yazmin Odia et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Radiosensitization of human glioma cells by tamoxifen is associated with the inhibition of PKC- activity in vitro
Lei Yang et al.
ONCOLOGY LETTERS (2015)
Tamoxifen enhances the anticancer effect of cantharidin and norcantharidin in pancreatic cancer cell lines through inhibition of the protein kinase C signaling pathway
Xin Xie et al.
ONCOLOGY LETTERS (2015)
In Vitro and In Vivo Effects of Tamoxifen against Larval Stage Echinococcus granulosus
Maria Celeste Nicolao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Tamoxifen reduces P-gp-mediated multidrug resistance via inhibiting the PI3K/Akt signaling pathway in ER-negative human gastric cancer cells
Zonglei Mao et al.
BIOMEDICINE & PHARMACOTHERAPY (2014)
Tamoxifen as the first targeted long-term adjuvant therapy for breast cancer
V. Craig Jordan
ENDOCRINE-RELATED CANCER (2014)
Beneficial role of tamoxifen in experimentally induced cardiac hypertrophy
Bhoomika M. Patel et al.
PHARMACOLOGICAL REPORTS (2014)
Tamoxifen use for the management of mania: a review of current preclinical evidence
Fernanda Armani et al.
PSYCHOPHARMACOLOGY (2014)
Mitochondria: The gateway for tamoxifen-induced liver injury
Mariana P. C. Ribeiro et al.
TOXICOLOGY (2014)
Estrogen Receptor Antagonists Are Anti-Cryptococcal Agents That Directly Bind EF Hand Proteins and Synergize with Fluconazole In Vivo
Arielle Butts et al.
MBIO (2014)
CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen
Paul L. Prather et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Tamoxifen magnifies therapeutic impact of ceramide in human colorectal cancer cells independent of p53
Samy A. F. Morad et al.
BIOCHEMICAL PHARMACOLOGY (2013)
4-Hydroxytamoxifen Induces Autophagic Death through K-Ras Degradation
Latika Kohli et al.
CANCER RESEARCH (2013)
The combination of the antiestrogen endoxifen with all-trans-retinoic acid has anti-proliferative and anti-migration effects on melanoma cells without inducing significant toxicity in non-neoplasic cells
Mariana P. C. Ribeiro et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Tamoxifen inhibits migration of estrogen receptor-negative hepatocellular carcinoma cells by blocking the swelling-activated chloride current
Jianwen Mao et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Selective estrogen receptor modulators inhibit hepatitis C virus infection at multiple steps of the virus life cycle
Yuko Murakami et al.
MICROBES AND INFECTION (2013)
Apoptotic effects of tamoxifen on leukocytes from horse peripheral blood and bronchoalveolar lavage fluid
J. Sarmiento et al.
VETERINARY RESEARCH COMMUNICATIONS (2013)
Protein Kinase C and Oxidative Stress in an Animal Model of Mania
Amanda Valnier Steckert et al.
CURRENT NEUROVASCULAR RESEARCH (2012)
Tamoxifen induces apoptosis of mouse microglia cell line BV-2 cells via both mitochondrial and death receptor pathways
Zhengwei Li et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2012)
Tamoxifen depresses glutamate release through inhibition of voltage-dependent Ca2+ entry and protein kinase Cot in rat cerebral cortex nerve terminals
Jinn-Rung Kuo et al.
NEUROCHEMISTRY INTERNATIONAL (2012)
Role of PKC-ERK signaling in tamoxifen-induced apoptosis and tamoxifen resistance in human breast cancer cells
Zhihua Li et al.
ONCOLOGY REPORTS (2012)
Induction of Autophagy and Cell Death by Tamoxifen in Cultured Retinal Pigment Epithelial and Photoreceptor Cells
Kyung Sook Cho et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Tamoxifen non-estrogen receptor mediated molecular targets
Tatiana Bogush et al.
ONCOLOGY REVIEWS (2012)
Tamoxifen and raloxifene suppress the proliferation of estrogen receptor-negative cells through inhibition of glutamine uptake
Valentina K. Todorova et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Voltage-dependent anion channel as a resident protein of lipid rafts: post-transductional regulation by estrogens and involvement in neuronal preservation against Alzheimer's disease
Jose Luis Herrera et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Tamoxifen enhances therapeutic effects of gemcitabine on cholangiocarcinoma tumorigenesis
Gu Jing et al.
LABORATORY INVESTIGATION (2011)
Progress in endocrine approaches to the treatment and prevention of breast cancer
Ifeyinwa Obiorah et al.
MATURITAS (2011)
Zinc(II) ion mediates tamoxifen-induced autophagy and cell death in MCF-7 breast cancer cell line
Jung Jin Hwang et al.
BIOMETALS (2010)
Potent inhibition of rhabdoid tumor cells by combination of flavopiridol and 4OH-tamoxifen
Velasco Cimica et al.
BMC CANCER (2010)
Molecular Mechanisms of Tamoxifen Therapy for Cholangiocarcinoma: Role of Calmodulin
Pritish Pawar et al.
CLINICAL CANCER RESEARCH (2009)
Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections
Danilo C. Miguel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Tamoxifen: Catalyst for the change to targeted therapy
V. Craig Jordan
EUROPEAN JOURNAL OF CANCER (2008)
Tamoxifen is effective against Leishmania and induces a rapid alkalinization of parasitophorous vacuoles harbouring Leishmania (Leishmania) amazonensis amastigotes
Danilo C. Miguel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Tamoxifen effect on L-DOPA induced response complications in parkinsonian rats and primates
C. P. S. Smith et al.
NEUROPHARMACOLOGY (2007)
Optimising endocrine approaches for the chemoprevention of breast cancer - Beyond the Study of Tamoxifen and Raloxifene (STAR) Trial
V. Craig Jordan
EUROPEAN JOURNAL OF CANCER (2006)
Estrogen receptors in pancreatic tumors
Makoto Satake et al.
PANCREAS (2006)
A phase II study of carboplatin and chronic high-dose tamoxifen in patients with recurrent malignant glioma
P. A. Tang et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Effects of oestradiol and tamoxifen on VEGF, soluble VEGFR-1, and VEGFR-2 in breast cancer and endothelial cells
S Garvin et al.
BRITISH JOURNAL OF CANCER (2005)
Tamoxifen: A most unlikely pioneering medicine
VC Jordan
NATURE REVIEWS DRUG DISCOVERY (2003)
Overview of the main outcomes in breast-cancer prevention trials
J Cuzick et al.
LANCET (2003)